EU - OHE - Page 33

Office of Health Economics

Leading intellectual authority on global health economics

Search publications, topics, authors and more

Newsletter SignupSubscribe

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Indication-Based Pricing
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Health Care Systems
Policy, Organisation and…
Healthcare Delivery

US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?

Drug Development/R&D
Economics of Innovation
Innovation

Innovation in Medicines: Can We Value Progress?

EQ-5D and PROMs
Measuring and Valuing Outcomes
Quality of Care

Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making

Measuring and Valuing Outcomes
Clinical Outcomes

Measuring Health Output, Productivity and Equity: Future Challenges

Health Policy and Regulation

Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries

Value-Based Pricing
Measuring and Valuing Outcomes
Determining Value

Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?

Health Care Systems
Policy, Organisation and…
Health Policy and Regulation

How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England

Real World Evidence (RWE)
Economics of Innovation
Research Funding

Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Indication-Based Pricing

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Indication-Based Pricing Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing

Tag

Select the product option you would like to filter Tag

Adult Immunisation Alzheimer's Broader value and societal perspective in HTA Budget Impact Analysis Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Diversity of Supply Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Health System Resiliency Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Respiratory Cost Calculator Saudi Arabia Slovak Republic Societal preferences Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Rosanna Tarricone Edwine Barasa Angela Kairu Neil Mcauslane Adam Raymakers Kiran Bhatti Kelsey Moore Meindert Boysen Pedro Pita Barros Andrew Briggs

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

Health Technology Assessment…
Value, Affordability, and…

Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research

Economics of Innovation
Clinical Outcomes

The Impact of New Medicines in the NHS: 70 Years of Innovation

Economics of Innovation
Health Policy and Regulation

Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS

Indication-Based Pricing
Economics of Innovation
Health Policy and Regulation

Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals

Economics of Innovation
Health Policy and Regulation

Establishing a Reasonable Price for an Orphan Drug

Drug Development/R&D
Economics of Innovation
Competition

R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C

Measuring and Valuing Outcomes
Cancer

Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology

Indication-Based Pricing
Economics of Innovation
Health Policy and Regulation

The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries

Emerging Markets
Economics of Innovation
Health Policy and Regulation

A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List”

News
January 2018

OHE at HESG Winter 2018

EQ-5D and PROMs
Measuring and Valuing Outcomes
Clinical Outcomes

New Methods for Analysing the Distribution of EQ-5D Observations

Economics of Innovation
Pharmaceutical Industry

The UK Biotech Sector and Brexit: Past Performance and Future Prospects

Health Data and Statistics
Epidemiology and Public Health

Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe?

Health Care Systems
Economics of Innovation
Quality of Care

Barriers to Uptake of Minimal Access Surgery in the United Kingdom

Health Technology Assessment…
Value, Affordability, and…
Rare and Orphan Diseases

Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence

Health Data and Statistics
Value, Affordability, and…

Real World Evidence for Coverage Decisions: Opportunities and Challenges

Leading intellectual authority on global health economics

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Cookies Policy

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Twitter

Facebook

Copy

Share on Mastodon

Enter your Mastodon instance URL (optional)

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Notifications